|
3-(苄基二甲基铵基)丙烷基磺酸
|
K026255-25g
|
99% |
81239-45-4 |
25g
|
¥ 1612.0
|
4~8周 |
|
0 |
科威 |
|
去氢胆酸
|
K004132-10g
|
98% |
81-23-2 |
10g
|
¥ 249.0
|
现货 |
|
0 |
科威 |
|
2,4-二氟苯乙酸
|
K011242-25g
|
99% |
81228-09-3 |
25g
|
¥ 920.0
|
现货 |
|
0 |
科威 |
|
2,4-二氟苯乙酸
|
K011242-5g
|
99% |
81228-09-3 |
5g
|
¥ 265.0
|
现货 |
|
0 |
科威 |
|
二环戊二烯环氧化物
|
K026254-5g
|
97% |
81-21-0 |
5g
|
¥ 224.0
|
4~8周 |
|
0 |
科威 |
|
2,6-二甲基硝基苯
|
K017384-500g
|
98% |
81-20-9 |
500g
|
¥ 1006.0
|
现货 |
|
0 |
科威 |
|
2,6-二甲基硝基苯
|
K017384-25g
|
98% |
81-20-9 |
25g
|
¥ 169.0
|
现货 |
|
0 |
科威 |
|
氘代甲醇-D4
|
K002894-10x0.6ml
|
(D,99.8%)+0.03% V/V TMS |
811-98-3 |
10x0.6ml
|
¥ 500.0
|
现货 |
|
0 |
科威 |
|
氘代甲醇-D4
|
K013066-10x0.6ml
|
D,99.8% (0.05% v/v TMS) |
811-98-3 |
10x0.6ml
|
¥ 500.0
|
现货 |
|
0 |
科威 |
|
氘代甲醇-D4
|
K013066-10g
|
D,99.8% (0.05% v/v TMS) |
811-98-3 |
10g
|
¥ 1081.0
|
现货 |
|
0 |
科威 |
|
α,α,2,6-四氯甲苯
|
K026253-100g
|
98% |
81-19-6 |
100g
|
¥ 1612.0
|
现货 |
|
0 |
科威 |
|
双(3,5,3'',5''-二甲氧基二亚苄基丙酮)钯(0)
|
K011033-5g
|
96% |
811862-77-8 |
5g
|
¥ 1334.0
|
4~8周 |
|
0 |
科威 |
|
双(3,5,3'',5''-二甲氧基二亚苄基丙酮)钯(0)
|
K011033-1g
|
96% |
811862-77-8 |
1g
|
¥ 379.0
|
4~8周 |
|
0 |
科威 |
|
3-溴-4-氟碘苯
|
K019288-25g
|
97% |
811842-30-5 |
25g
|
¥ 1302.0
|
现货 |
|
0 |
科威 |
|
3-溴-4-氟碘苯
|
K019288-5g
|
97% |
811842-30-5 |
5g
|
¥ 326.0
|
现货 |
|
0 |
科威 |
|
2-氨基-1-(丁基二甲基硅氧基)丁烷
|
K019418-5g
|
98% |
811841-81-3 |
5g
|
¥ 1496.0
|
4~8周 |
|
0 |
科威 |
|
Apatinib
|
K026252-10mg
|
99% |
811803-05-1 |
10mg
|
¥ 2687.0
|
4~8周 |
|
0 |
科威 |
|
Apatinib
|
K026252-5g
|
99% |
811803-05-1 |
5g
|
¥ 20160.0
|
4~8周 |
|
0 |
科威 |
|
Apatinib
|
K026252-50mg
|
99% |
811803-05-1 |
50mg
|
¥ 9407.0
|
4~8周 |
|
0 |
科威 |
|
二苯亚甲基甘氨酸甲酯
|
K016104-1g
|
97% |
81167-39-7 |
1g
|
¥ 95.0
|
现货 |
|
0 |
科威 |
|
二苯亚甲基甘氨酸甲酯
|
K016104-25g
|
97% |
81167-39-7 |
25g
|
¥ 866.0
|
现货 |
|
0 |
科威 |
|
二苯亚甲基甘氨酸甲酯
|
K016104-5g
|
97% |
81167-39-7 |
5g
|
¥ 296.0
|
现货 |
|
0 |
科威 |
|
2-萘胺-1-磺酸
|
K015209-500g
|
98% |
81-16-3 |
500g
|
¥ 156.0
|
现货 |
|
0 |
科威 |
|
2-萘胺-1-磺酸
|
K015209-25g
|
98% |
81-16-3 |
25g
|
¥ 50.0
|
现货 |
|
0 |
科威 |